Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration 

 

 

StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration

June 21, 2012 - (StemCells, Inc.) - "StemCells, Inc. today announced initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in dry age-related macular degeneration (AMD) referred to as Geographic Atrophy. There are no approved treatments for dry AMD."  Read Full Article

 

Posted on 2-Jul-12 by Toto, Brent
Tags:
 
Trackback Url  |  Link to this post | Bookmark this post with: